Crossmark

Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapy

Crossref DOI link: https://doi.org/10.1186/s12879-018-3203-9

Published Online: 2018-07-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rekha, Rokeya Sultana

Mily, Akhirunnesa

Sultana, Tajnin

Haq, Ahsanul

Ahmed, Sultan

Mostafa Kamal, S. M.

van Schadewijk, Annemarie

Hiemstra, Pieter S.

Gudmundsson, Gudmundur H.

Agerberth, Birgitta

Raqib, Rubhana
Funding

Funding for this research was provided by:

International Centre for Diarrhoeal Disease Research, Bangladesh (BD) (SWE-2008-065)

Stiftelsen för Strategisk Forskning (SE) (RBd08-0014)

Hjärt-Lungfonden (2013-0366)

Vetenskapsrådet (2016-01496)
License Information

Text and Data Mining valid from 2018-07-04
More Information

Article History

Received: 4 October 2017

Accepted: 22 June 2018

First Online: 4 July 2018

Ethics approval and consent to participate

: The study was approved by the Research and Ethical Review Committees at the icddr,b Dhaka, Bangladesh. Written informed consent was obtained from patients before enrollment into the study that included permission to store specimens for future use.

: Not applicable.

: All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.